BSE filing, BSE: 540468. Summary written from the filing by ALFA Finder's alert engine.
More from Kms Medisurgi Ltd
All →KMS Medisurgi H2 FY26 Results: Net Profit ₹0 Cr
KMS Medisurgi Ltd reported revenue from operations of ₹5.6 Cr (-8.2% YoY) and net profit of ₹0 Cr for H2 FY26.
- Key figure
- Net profit ₹0 Cr
Kms Medisurgi Financial Results
KMS Medisurgi Limited reported audited standalone financial results for the year ended March 31, 2026. The results include a qualified auditor's opinion regarding stock records and employee benefits.
Kms Medisurgi Board Meeting Date
KMS Medisurgi scheduled a board meeting for May 30, 2026, to approve annual audited financial results. Trading window remains closed until 48 hours post-announcement.
Kms Medisurgi Other Announcement
KMS Medisurgi Limited submitted a non-applicability declaration regarding corporate governance reports for the year ended March 31, 2026. As an SME-listed entity, the company is exempt from these specific SEBI LODR disclosure requirements under Regulation 15(2).
Other other announcement announcements
All →Gconnect Logitech and Supply Chain Other Announcement
Gconnect Logitech appointed HD and Associates LLP as Secretarial Auditor for a 60-month term effective October 30, 2026. The routine appointment carries no financial impact disclosed.
- Execution
- 60 months
Arvind Port and Infra Other Announcement
Arvind Port and Infra reported no deviation in use of its preferential warrant proceeds for the half year. The audit committee reviewed the statement.
EPack Prefab Technologies Other Announcement
EPACK Prefab authorised named KMPs to determine materiality and make disclosures under Regulation 30(5). The filing lists their contact details only.
Indogulf Cropsciences Other Announcement
Indogulf Cropsciences filed its Monitoring Agency Report for the quarter ended September 30, 2026, covering IPO proceeds of Rs 200 crore. The report states no deviation from the objects of the issue.
Sun Pharma Advanced Research Company Other Announcement
Sun Pharma Advanced Research filed its monitoring agency report on warrant issue proceeds for the quarter ended September 30, 2026. The agency found no deviation from objects.
JM Financial Other Announcement
JM Financial filed its quarterly shareholding pattern for the quarter ended 30 September 2025. It is a periodic disclosure with no transaction, money or corporate event.